BCL2L1 and inflammatory bowel disease: RNF183-mediated ubiquitylation of substrates, Bcl-xL, IκBα, and DR5, and the negative regulation of RNF183 by miR-7 may be important novel epigenetic mechanisms in the pathogenesis of IBD.